Ambiguous Regulations Can Hamstring Earning Proof of Fraud

A recent whistleblower case decision has revealed how federal prosecutors going after providers for fraud have been frustrated by the murkiness of federal regulations.

United States Ex Rel. Deborah Sheldon v. Allergan Sales, LLC is in many ways a typical whistleblower qui tam case. It involves allegations against Allergan, formerly Forest Laboratories, and its corporate compliance with complex, inscrutable Medicaid pricing and rebate regulations. Despite the superficial banality of the case, it raises some important considerations.

This case furthers the circuit court split regarding key concepts in False Claims Act (FCA) litigation. In the decision, the majority cites the legal experts of Calvin and Hobbes, noting that “people have asked how to play Calvinball. It’s pretty simple: you make up the rules as you go.”

That quote is one of the best parts of this decision from a divided three-judge panel of the Fourth Circuit. It summarizes the frustrations inherent in dealing with Centers for Medicare & Medicaid Services (CMS) regulations. I expect this decision to be appealed due to the inter-circuit disparities – and the $680 million on the line. But for now, this decision is the law in the Fourth Circuit.

The case turns on the defendant’s knowledge of falsity.

As a quick review, the FCA imposes liability on anyone who “knowingly” makes or uses a false or fraudulent claim. The statute defines knowingly as:

  • Having actual knowledge; or
  • Deliberate ignorance; or
  • Reckless disregard of the truth or falsity of the information.

This knowledge is referred to as “scienter” in legal-speak. If someone lacks any of the legal knowledge requirements, fraud cannot be proved. It is this knowledge requirement that largely defines the outcome of this case.

It’s worth recalling that liability under the FCA requires no proof of intent to defraud.

As with most things in law, we also must consider two types of falsity: legal and factual. The straightforward case is factual falsity; this occurs when a false statement of a fact is made, such as saying that 100 items were sold when the actual sale was 50. In contrast, legal falsity arises when the claim is factually correct, but compliance with underlying statutes, regulations, or contract terms is knowingly misrepresented. The Sheldon case (and many others) relate to legal falsity. This is because following the guidance imposed by statutes or regulations may not be as straightforward as we’d like.

The majority opinion in the case dispenses with the case by concluding that the defendant did not act knowingly, so it need not address the falsity question. So why, you might ask, did the court conclude that the defendant did not act knowingly?

This is where things get murky. The three-judge panel disagrees based on potentially flawed logic and misapplication of legal precedent. But there are some transcendent messages we can glean from the judges’ dispute.

The clear message is that if the law or regulation is ambiguous, then under some circumstances, fraud may not even be possible. The court is divided over where the “ambiguity line” might be drawn. To take advantage of an ambiguity defense, you will probably need the following:

  • A belief that you’re not committing an illegal act. The courts are divided as to whether that should be an objective or subjective standard.
  • Next, your belief needs to be based on a combination of several things, including:
    • The wording of the applicable statute and regulations;
    • Any subsequent guidance related to the alleged ambiguity; and
    • Possibly, your attorney’s advice.

The bottom line is this: be sure to exhaustively research available guidance. Use the most conservative guidance available, and make sure your conclusions are objectively and subjectively realistic.

Read the decision in its entirety here.

Other useful references:

https://www.justice.gov/sites/default/files/civil/legacy/2011/04/22/C-FRAUDS_FCA_Primer.pdf

https://www.law.cornell.edu/wex/fraud

https://www.weil.com/~/media/files/pdfs/understanding-the-false-claims-act-(75611346).pdf

Facebook
Twitter
LinkedIn

John K. Hall, MD, JD, MBA, FCLM, FRCPC

John K. Hall, MD, JD, MBA, FCLM, FRCPC is a licensed physician in several jurisdictions and is admitted to the California bar. He is also the founder of The Aegis Firm, a healthcare consulting firm providing consultative and litigation support on a wide variety of criminal and civil matters related to healthcare. He lectures frequently on black-letter health law, mediation, medical staff relations, and medical ethics, as well as patient and physician rights. Dr. Hall hopes to help explain complex problems at the intersection of medicine and law and prepare providers to manage those problems.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24